Summary
The frequencies of 13 different Ha-ras proto-oncogene alleles have been estimated in 92 breast cancer patients and 60 unaffected individuals. The Ha-ras alleles can be identified using a DNA restriction fragment length polymorphism (RFLP) closely linked to the 3′ end of the gene, and are characterized by a different length due to a region of sequences repeated a variable number of times (variable tandem repeats, VTR).
The statistical analysis of the data obtained shows that the frequency of alleles ranging between specific length limits is significantly higher in breast cancer patients than in controls. The same applies to specific genotypes bearing the aforementioned alleles. This suggests that the inheritance of these alleles may be associated with an increased risk of developing breast cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Pulciani S, Santos E, Lauver AV, Long LK, Aaronson SA, Barbacid M: Oncogenes in solid human tumors. Nature 300: 539–542, 1982
Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH: Mechanism of activation of a human oncogene. Nature 300: 143–149, 1982
Reddy EP, Reynolds RK, Santos E, Barbacid M: A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149–152, 1982
Taparowsky E, Suard Y, Fasano O, Shimuzu K, Goldfarb M, Wigler A: Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300: 762–765, 1982
Yuasa Y, Srivastava SK, Dunn CY, Rhim JS, Reddy EP, Aaronson SA: Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature 303: 775–779, 1983
Cichutek K, Duesberg PH: Harvey ras genes transform without mutant codons apparently activated by truncation of a 5′ exon (exon −1). Proc Natl Acad Sci USA 83: 2340–2344, 1986
Stacey DW, Kung HF: Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 310: 508–511, 1984
Horan-Hand PH, Thor A, Wunderlich D, Muraro R, Caruso A, Schlom J: Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary carcinomas. Proc Natl Acad Sci USA 81: 5227–5231, 1984
De Bortoli ME, Abou-Issa H, Haley BE, Cho-Chung YS: Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents. Biochem Biophys Res Commun 127: 699–706, 1985
Barbacid M: Oncogenes in human cancer and chemically induced animal tumors. Prog Med Virol 32: 86–100, 1985
Goldfarb N, Shimuzu K, Perucho M, Wrigler M: Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cell. Nature 296: 404–409, 1982
Krontiris TG, DiMartino NA, Colb M, Parkinson DR: Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients. Nature 313: 369–374, 1985
Thein SL, Oscier DG, Flint J, Wainscoat JS: Ha-ras hypervariable alleles in myelodysplasia. Nature 321: 84–85, 1986
Gerhard DS, Dracopoli NC, Bale SJ, Houghton AN, Watkins P, Payne CE, Greene MH, Housman DE: Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature 325: 73–75, 1987
Lidereau R, Escot C, Theillet C, Champeme MH, Brunet M, Gest J, Callahan R: High frequency of rare alleles of the human c-Ha-ras 1 proto-oncogene in breast cancer patients. J Natl Cancer Inst 77: 697–701, 1986
Theillet C, Lidereau R, Escot C, Hutzell P, Brunet M, Gest J, Schlom J, Callahan R: Loss of a c-Ha-ras 1 allele and aggressive human primary breast carcinomas. Cancer Res 46: 4776–4781, 1986
Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WK: Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature 309: 170–172, 1984
Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, DeLena M, Tancini G, Baietta E, Musumeci R, Veronesi U: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 406–411, 1976
Southern E: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–509, 1975
Santos E, Tronick SR, Aaronson SA, Pulciani S, Barbacid M: T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of Balb- and Harvey-MSV transforming genes. Nature 298: 343–347, 1982
Morton NE: Outline of Genetic Epidemiology. Karger, Basel, 1982
Chandler LA, Ghazi H, Jones PA, Boukamp P, Fusening NE: Allele-specific methylation of the human c-Ha-ras-1 gene. Cell 50: 711–717, 1987
Ishii S, Nagase T, Imamoto F: Enhancer element of the human Harvey ras proto-oncogene and its polymorphism in human DNA (Abstract). Second Annual Meeting on Oncogenes, Hood College, Frederick (Maryland), 111, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saglio, G., Camaschella, C., Giai, M. et al. Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population. Breast Cancer Res Tr 11, 147–153 (1988). https://doi.org/10.1007/BF01805838
Issue Date:
DOI: https://doi.org/10.1007/BF01805838